Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma

Clinical trial NCT06017323 · WITHDRAWN

Trial details

NCT number: NCT06017323
Sponsor: Georgetown University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2023-10-01
Primary completion: 2026-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.